Anetta Reszko
Dermatology · New York, NYNPI 1114186400
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,725 of the $22,526 with a category attached, or 60.9%. Galderma Laboratories, L.p. accounts for 67.2% of it on its own, with 15 other manufacturers making up the rest. Reporting peaked in 2020 at $10,383 and has fallen 91.4% since, to $897 in 2025.
Across 121 payments — averaging $186.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$15K
- Merz North America, Inc.$6K
- AbbVie$701
- Solta Medical, A Division Of Bausch Health US, LLC$140
- Almirall LLC$89
- Johnson & Johnson$80
- plus $303 from 10 others
What the payments were for
- Consulting fees$2,25010%
- Speaking & faculty fees$13,72561%
- Travel & lodging$1,7318%
- Food & beverage$4,82021%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 46 | $15,127 |
| Merz North America, Inc. | 28 | $6,086 |
| AbbVie(2 entities) | 21 | $701 |
| Solta Medical, A Division Of Bausch Health US, LLC | 6 | $140 |
| Almirall LLC | 4 | $89 |
| Johnson & Johnson | 3 | $80 |
| Sun Pharmaceutical Industries Inc. | 2 | $50 |
| Pfizer | 2 | $48 |
| Dermavant Sciences, Inc. | 2 | $44 |
| Novartis | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| LEO Pharma Inc. | 1 | $27 |
| UCB, Inc. | 1 | $25 |
| Arcutis Biotherapeutics, Inc. | 1 | $24 |
| Strata Skin Sciences, Inc. | 1 | $15 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XEOMIN$2,857
- ASCLERA$311
- BOTOX COSMETIC$271
- DYSPORT$128
How this compares
$22,526 in reported general payments places this provider in the 85th percentile of 1,151 dermatology providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Imiquimod | 79 | $1,918 |
| ValacyclovirValacyclovir Hcl | 66 | $1,000 |
| Clobetasol Propionate | 26 | $682 |
| Clindamycin Phosphate | 19 | $547 |
| Mupirocin | 57 | $492 |
| Fluorouracil | 11 | $489 |
| Triamcinolone Acetonide | 46 | $454 |
| Minoxidil | 38 | $324 |
| Ketoconazole | 16 | $254 |
| Nystatin | 12 | $199 |
| Spironolactone | 12 | $84 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New York
- Alexandra GolantNew York$3.6M
- David CohenNew York$3M
- Michael CameronNew York$2.6M
- Saakshi KhattriNew York$2.4M
- Amy WechslerNew York$2.4M
- Joshua ZeichnerNew York$2.1M
- Emma GuttmanNew York$1.7M
- George HanNew York$1.6M
- Amy SpizuocoNew York$1.3M
- Andrew AlexisNew York$834K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.